Ingredients in fruit juices interact with dasatinib through inhibition of BCRP: a new mechanism of beverage-drug interaction
- PMID: 25418056
- DOI: 10.1002/jps.24289
Ingredients in fruit juices interact with dasatinib through inhibition of BCRP: a new mechanism of beverage-drug interaction
Abstract
Small molecule tyrosine kinase inhibitors (TKIs) are a group of highly novel and target-specific anticancer drugs. Recently, most TKIs are found to be substrates of P-glycoprotein (P-gp) and Breast Cancer Resistance Protein (BCRP). However, little information is available regarding the Pgp- or BCRP-mediated interaction of TKIs with coadministered drugs/food/beverage. Our objective was to evaluate the effect of the major ingredients of grapefruit juice (GFJ), orange juice (OJ), apple juice (AJ), and green tea on P-gp and BCRP-mediated dasatinib efflux. Among the 14 ingredients screened, only tangeretin and nobiletin moderately inhibited P-gp-mediated dasatinib efflux. In contrast, four ingredients in GFJ [i.e., bergamottin, 6',7'-dihydroxybergamottin (DHB), quercetin, and kaempferol], two ingredients in OJ (tangeretin and nobiletin), and one ingredient in AJ (i.e., hesperetin) greatly inhibited BCRP-mediated dasatinib efflux at the concentration of 50 μM (p < 0.001). Further concentration-dependent studies revealed that bergamottin, DHB, tangeretin, and nobiletin are potent BCRP inhibitors, with IC₅₀ values 3.19, 5.2, 1.19, and 1.04 μM, respectively. Further in vivo investigations are warranted to evaluate the BCRP-mediated FJ-TKI interaction. Literature reports only documented the modulatory effect of FJ and green tea on CYP3A, P-gp, and OATP. Our novel finding that FJ ingredients strongly inhibit BCRP may represent a new mechanism of beverage-drug interaction.
Keywords: ABC transporters; drug interactions; drug transport; food interactions; natural products; tyrosine kinase inhibitor.
© 2014 Wiley Periodicals, Inc. and the American Pharmacists Association.
Similar articles
-
TKI combination therapy: strategy to enhance dasatinib uptake by inhibiting Pgp- and BCRP-mediated efflux.Biopharm Drug Dispos. 2016 Oct;37(7):397-408. doi: 10.1002/bdd.2022. Epub 2016 Sep 13. Biopharm Drug Dispos. 2016. PMID: 27418107
-
Interaction of the efflux transporters ABCB1 and ABCG2 with imatinib, nilotinib, and dasatinib.Clin Pharmacol Ther. 2014 Mar;95(3):294-306. doi: 10.1038/clpt.2013.208. Epub 2013 Oct 9. Clin Pharmacol Ther. 2014. PMID: 24107928 Review.
-
The bioflavonoid kaempferol is an Abcg2 substrate and inhibits Abcg2-mediated quercetin efflux.Drug Metab Dispos. 2011 Mar;39(3):426-32. doi: 10.1124/dmd.110.035212. Epub 2010 Dec 7. Drug Metab Dispos. 2011. PMID: 21139040
-
P-glycoprotein and breast cancer resistance protein influence brain distribution of dasatinib.J Pharmacol Exp Ther. 2009 Sep;330(3):956-63. doi: 10.1124/jpet.109.154781. Epub 2009 Jun 2. J Pharmacol Exp Ther. 2009. PMID: 19491323
-
Functions of the breast cancer resistance protein (BCRP/ABCG2) in chemotherapy.Adv Drug Deliv Rev. 2009 Jan 31;61(1):26-33. doi: 10.1016/j.addr.2008.07.003. Epub 2008 Dec 3. Adv Drug Deliv Rev. 2009. PMID: 19111841 Review.
Cited by
-
Pharmacokinetics of Dasatinib in Rats: a Potential Food-Drug Interaction with Naringenin.Eur J Drug Metab Pharmacokinet. 2024 Mar;49(2):239-247. doi: 10.1007/s13318-024-00881-9. Epub 2024 Feb 20. Eur J Drug Metab Pharmacokinet. 2024. PMID: 38376657
-
Polymethoxylated flavonoids in citrus fruits: absorption, metabolism, and anticancer mechanisms against breast cancer.PeerJ. 2024 Jan 3;12:e16711. doi: 10.7717/peerj.16711. eCollection 2024. PeerJ. 2024. PMID: 38188169 Free PMC article.
-
Herb-drug interaction: Effect of sinapic acid on the pharmacokinetics of dasatinib in rats.Saudi Pharm J. 2023 Nov;31(11):101819. doi: 10.1016/j.jsps.2023.101819. Epub 2023 Oct 5. Saudi Pharm J. 2023. PMID: 37860687 Free PMC article.
-
Dasatinib: a potential tyrosine kinase inhibitor to fight against multiple cancer malignancies.Med Oncol. 2023 May 10;40(6):173. doi: 10.1007/s12032-023-02018-5. Med Oncol. 2023. PMID: 37165283 Review.
-
Effects of Apigenin on Pharmacokinetics of Dasatinib and Probable Interaction Mechanism.Molecules. 2023 Feb 7;28(4):1602. doi: 10.3390/molecules28041602. Molecules. 2023. PMID: 36838589 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous